Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Quad Sevens who wrote (2975)	6/12/1998 12:59:00 AM
From: R. M. Rosenthal	Respond to of 5736

The way I see it, during the days, weeks and months following announcement of international distribution and manufacturing agreement(s) for CCSI's Non-Invasive TLcBili-Test procedure, the worldwide media will be deluged with stories about it. Newborns: Many of them used to have to be subjected, along with their parents, to a repetition of painful and even potentially dangerous heel pricks. the not always easy and often traumatic task of trying to draw blood from tiny little feet to see whether a certain life threatening liver condition might be present. Now, thanks to CCSI's revolutionary new Tender Loving care Bili-test, that kind of thing longer has to happen, bla bla bla. In newspapers, magazines and TV from Boston to Beijing, Mom&pops tobe will see shots of non-wailing, non-weeping babies, smiling moms. smiling nurses, smiling Docs. Even smiling HMOs because certain risks attendant to drawing blood will be eliminated. That a person or group of people acting in concert (stay tuned!!!) may have contrived to deprive the world of this life enhancing procedure- that just makes it a much, much juicer story, because now we've got the actual face of evil; a genuine smoke &mirrors, lie-spewing villain, ready to say (or omit) anything/ ruin anyone, for the simple sake of another silk suit. A modern-day predator, wielding the Nazi's old Big Lie Technique to bludgeon the truth and anyone who honors it. Yes indeed, Big story here, IMO. Perfect opportunity for politicians, regulators, SEC, NASD, etc., to all jump on the bandwagon, show us how hard they're all working to protect us from bad guys like this who'd make it tough on little babies. Great opportunity to make an example. No mere slap on the wrist and a fine, this time around.

To: Quad Sevens who wrote (2975)	6/12/1998 7:12:00 AM
From: STLMD	Read Replies (3) \| Respond to of 5736

Wade, please be careful in confusing charges with reimbursement. A hospital lab may charge 22-36 dols. for a test but with respect to reimbursement, this varies from Medicare paying $6-7 and private insurers $8-14. So in evaluating the price an institution will pay for the disposable one must take reimbursement into account. Let's say the lab tech's time is eliminated from the equation, we still have some time from the nurse doing the testing, so I assume the time factor is a wash. The cost for the machine to do the run in the lab is estimated at about $2-5 depending upon the frequency of testing and equipment. I am skeptical of Dr. Maisels statements in defense of the company since he has been a lifetime proponent of much less aggressive bilirubin monitoring since the incidence of kernicterus is quite low to nonexistent(research his past pre-CCSI affiliation articles). In addition, as I posted in previous notes the FDA 510k states that out of over 1300 babies in the study only 170 underwent the Colormate III because the others did not have jaundice. It's right there in print. How can we now assume that the market will be 90% of all infants as Dr. Maisels predicts? This is a great device. I anticipate it will replace a lot of the current marketplace. I admit I do not know what role parental demand will play in this market but to base future earnings revenue on statements such as all parents will demand to have their infants tested, etc. is investor's folly. Finally, the Dreyfus affair is the catalyst to this entire short position portrayed by Asensio. He knew about it, knew that Dreyfus would be dumping their shares, knew that disclosure by the fund manager was not done, and knows just enough about the bili market to weave a carefully woven trail of mistruths. I ask all longs to do their homework based on probably at the maximum 5 million tests per year(15 mil x 33% penetration) although I feel the 15 million may be high. What usually holds up distribution arrangements? Lawyers and Money, right? I for one believe the money is the key here and the major bone of contention between the company's expectations and the reality of the marketing world as seen by the distributor. Good luck, wise and thorough investing to all longs. Stephen